Lin Patrick
Chief Business - Strategy Off · 8 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | PCSA | Processa Pharmaceuticals, Inc. | Buy | 2,106 | $1.93 | $4,064.58 | filing |
| 2026-06-15 | PCSA | Processa Pharmaceuticals, Inc. | Buy | 1,831 | $2.22 | $4,064.82 | filing |
| 2026-05-29 | PCSA | Processa Pharmaceuticals, Inc. | Buy | 1,582 | $2.57 | $4,065.74 | filing |
| 2026-05-15 | PCSA | Processa Pharmaceuticals, Inc. | Buy | 1,369 | $2.97 | $4,065.93 | filing |
| 2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Buy | 1,511 | $2.69 | $4,064.59 | filing |
| 2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Buy | 1,369 | $2.97 | $4,065.93 | filing |
| 2026-03-31 | PCSA | Processa Pharmaceuticals, Inc. | Buy | 1,603 | $2.54 | $4,063.61 | filing |
| 2026-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Option exercise | 193 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.